JoVE Logo

Zaloguj się

Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

W tym Artykule

  • Podsumowanie
  • Streszczenie
  • Wprowadzenie
  • Protokół
  • Reprezentatywne Wyniki
  • Dyskusje
  • Ujawnienia
  • Podziękowania
  • Materiały
  • Odniesienia
  • Przedruki i uprawnienia

Podsumowanie

This protocol describes a method for facilitating the collection of samples from radical prostatectomy specimens. The goal is to map, characterize, and micro-macro dissect tissue samples from the specimens based on anatomopathological criteria before storing them in a Biobank.

Streszczenie

Acquiring fresh and well-characterized tumor tissue samples is critical for conducting high-quality "omics" studies. However, it can be particularly challenging in the context of prostate cancer (PC) due to the unique nature of this organ and the high heterogeneity associated with this tumor. On the other hand, histopathologically characterizing samples before their storage without causing significant tissue alterations is also an intriguing challenge. In this context, we present a new method for acquiring, mapping, characterizing, and micro-dissecting resected prostate tissue based on anatomopathological criteria.

Unlike previously published protocols, this method reduces the time required for histopathological analysis of the prostate specimen without compromising its structure, which is crucial for assessing surgical margins. Furthermore, it enables the delineation and micro-macro dissection of fresh prostate tissue samples, with a focus on histological tumor areas defined by pathological criteria such as Gleason score, precursor lesions (high-grade prostatic intraepithelial neoplasia - PIN), and inflammatory lesions (prostatitis). These samples are then stored in a Biobank for subsequent research analyses.

Wprowadzenie

Prostate cancer (PC) is the 2nd most frequent cancer in men and the 5th leading cause of death worldwide1. Patient treatment and prognosis depend on the staging and grading (Gleason score) of the tumor, as evidenced by the higher 5-year survival rates of localized and low-grade tumors (Gleason grade 6) (99%) compared to high Gleason grades and metastatic tumors (31%)2.

PC local relapse and treatment failure have been linked to the characteristic high genetic intratumor heterogeneity of this tumor type3. Additionally, PC is considered to be a multif....

Protokół

This method was developed through collaborative efforts involving different clinical services (Urology, Pathology, and the La Fe Hospital Biobank). The study was conducted in compliance with institutional, national, and international guidelines for human welfare, and it received approval from the Ethics Committee for Biomedical Research at the Instituto de Investigación Sanitaria Hospital Universitario y Politécnico La Fe (Valencia, Spain). All samples were stored at the La Fe Hospital Biobank (PT13/0010/0026). The overall procedure is detailed in Figure 1.

<....

Reprezentatywne Wyniki

The results reveal that this technique has made it possible to obtain tumor material in 61% of the cases studied (25 out of 41 cases) (Table 1).

Table 1: Histopathological data of study samples. Summary of histopathological data for the samples used in the study. The diagnostic cylinder refers to the prostate biopsy sample obtained for diagnostic purposes, while the processed cylinder corresponds to the cylinder obtained from the prostatectomy specimen for res.......

Dyskusje

In any research study, obtaining quality samples is an essential requirement to reduce systematic biases and obtain reliable results22. Therefore, control of preanalytical variables such as the temperature at which samples are processed and stored, the time elapsed from sample collection to storage, the use of sterilized materials, or the effects that the addition of preservatives or other additives can have on samples must be considered in any protocol involving biological samples. Not only is th.......

Ujawnienia

The authors declare no conflict of interest.

Podziękowania

A.L. acknowledges a "Margarita Salas" postdoctoral contract (number 21-076), and MAM-T a 'Maria Zambrano' research contract (number MAZ/2021/03 UP2021-021). Both contracts have been funded by the European Union-Next generation EU.

....

Materiały

NameCompanyCatalog NumberComments
Cadiere forcepsIntuitivePN1052082-US 10/2021Part number: 471049. 18 uses.
Conventional slidesKnittel Glass2021Ground/ Frosted end
Cryostat microtomeThermo Fisher Scientific---Criostato CryoStar NX50
CryotubesGreiner Bio-One GmbHRef.: 122280.CRYO S. PP, with screw cap, sterile. 
Da Vinci surgical systemIntuitivePN1052082-US 10/2021XI model
Dissection instrumentsBayer---Two tweezers and a surgical blade 
DPX Eukitt Medizin- und Labortechnik GmbH6.00.01.0001.06.01.01
EosinAgilent157252
Fenestrated bipolar forcepsIntuitivePN1052082-US 10/2021Part number: 471205. 14 lives.
Force bipolarIntuitivePN1052082-US 10/2021Part number: 471405. 12 uses.
FreezersThermo ScientificMODEL 907. -80 ºC
HematoxylinAgilent157251
Inmunohistochemistry SlidesAgilent-DakoK802021-2
Large needle driverIntuitivePN1052082-US 10/2021Part number: 471006. 15 uses.
Maryland bipolar forcepsIntuitivePN1052082-US 10/2021Part number: 471172. 14 uses.
MicroscopeOlympus---Olympus cx40
Microtome bladesPFM Medicala35
Monopolar curved scissorsIntuitivePN1052082-US 10/2021Part number: 470179. 10 uses.
OCT compoundNEG-50LOT.117340
PlusSpeed S Single-use Biopsy Device with beveled tipPeter Pflugbeil GmbH PSS-1825-S
ProGasp forcepsIntuitivePN1052082-US 10/2021Part number: 471093. 18 uses.
Sample holder DiscDavidson Cryo Chuck. BradleyProducts30 mm 
Tissue inkPelikan2021Ink 4001 brilliant black (301168)
XylolQuimipurRef. 169

Odniesienia

Przedruki i uprawnienia

Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE

Zapytaj o uprawnienia

Przeglądaj więcej artyków

Prostate TumorBiobankingTumor SamplingHistological CharacterizationProstate CancerGleason ScoreHGPINProstatitisMicro dissectionTissue Preservation

This article has been published

Video Coming Soon

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone